Literature DB >> 15763590

Synthesis of biologically active steroid derivatives by the utility of Lawesson's reagent.

Nadia R Mohamed1, Gamal A Elmegeed, Hoda A Abd-ElMalek, Magdi Younis.   

Abstract

Steroid derivatives V, VI, VII and VIII reacted with Lawesson's reagent (LR) to produce spiro-oxazaphosphole-4',17-androstene derivative XI, diazaphospholoandrostane XIV and the thionated derivatives XVI and XVII, respectively. The structures of the new compounds were confirmed by analytical and spectroscopic evidence. A mechanism accounting for the formation of the new compounds was given. The in vitro antimicrobial activity of the new compounds were tested.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15763590     DOI: 10.1016/j.steroids.2004.11.001

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  4 in total

1.  Synthesis, characterization and biological evaluation of some novel P-heterocyclic androst-4-ene derivatives.

Authors:  Natalija M Krstić; Vladimir D Pavlović; Irena T Novaković; Ivana Z Matić; Dušan M Sladić
Journal:  Mol Divers       Date:  2013-06-09       Impact factor: 2.943

2.  Synthesis of novel steroidal 16-spiroisoxazolines by 1,3-dipolar cycloaddition, and an evaluation of their antiproliferative activities in vitro.

Authors:  Éva Frank; Dóra Kovács; Gyula Schneider; János Wölfling; Tibor Bartók; István Zupkó
Journal:  Mol Divers       Date:  2014-04-02       Impact factor: 2.943

3.  Synthesis of New Functionally Substituted 9-Azabicyclo[4.2.1]nona-2,4,7-trienes by Cobalt(I)-Catalyzed [6π + 2π]-Cycloaddition of N-Carbocholesteroxyazepine to Alkynes.

Authors:  Gulnara N Kadikova; Vladimir A D'yakonov; Usein M Dzhemilev
Journal:  Molecules       Date:  2021-05-14       Impact factor: 4.411

4.  Assessment of the Antitumor Potentiality of Newly Designed Steroid Derivatives: Pre-Clinical Study.

Authors:  Dina S El-Kady; Naglaa A Ali; Alaa H Sayed; Mervat M Abdelhaliem; Gamal A Elmegeed; Hanaa H Ahmed
Journal:  Asian Pac J Cancer Prev       Date:  2019-10-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.